Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01975519
Title A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.
Indications

sarcoma

Therapies

Carotuximab + Pazopanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.